Electrode

EAF IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GrafTech International Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EAF

Retrieved on: 
Sunday, March 17, 2024

WHAT TO DO NEXT: To join the GrafTech class action, go to https://rosenlegal.com/submit-form/?case_id=22210 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the GrafTech class action, go to https://rosenlegal.com/submit-form/?case_id=22210 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2024.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

EAF DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages GrafTech International Ltd. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EAF

Retrieved on: 
Friday, March 15, 2024

WHAT TO DO NEXT: To join the GrafTech class action, go to https://rosenlegal.com/submit-form/?case_id=22210 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the GrafTech class action, go to https://rosenlegal.com/submit-form/?case_id=22210 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes

Retrieved on: 
Tuesday, April 9, 2024

EDEN PRAIRIE, Minn., April 09, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the first implant of its OneRF™ Ablation electrode by doctors at a top ranked hospital in the US, as ranked by the US News & World Best Hospital Report in its 2023-2024 publication. The OneRF™ Ablation system has FDA 510(k) clearance for creation of radiofrequency (“RF”) lesions in nervous tissue for functional neurosurgical procedures.

Key Points: 
  • The OneRF™ Ablation system has FDA 510(k) clearance for creation of radiofrequency (“RF”) lesions in nervous tissue for functional neurosurgical procedures.
  • “We are excited to announce that yesterday, doctors implanted Evo® sEEG-RF electrodes in a patient suffering from epilepsy.
  • Once the monitoring identifies the areas of the brain that are causing seizures, the surgical team now has the option to use the same electrodes to perform an ablation utilizing NeuroOne’s RF generator.
  • NeuroOne now boasts a full line of thin film electrode technology to address patients requiring diagnostic brain mapping procedures as well as RF ablation using the same sEEG electrode.

Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device

Retrieved on: 
Thursday, April 4, 2024

HOUSTON, TX, April 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No.

Key Points: 
  • HOUSTON, TX, April 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No.
  • The newly issued patent, entitled, “Transcranial Alternating Current Dynamic Frequency Stimulation Method for Anxiety, Depression and Insomnia (ADI),” covers the method of use utilized in the Company’s Gen-3 HALO Clarity™ system.
  • Mark White, CEO of Nexalin Technology, stated, “This method of use patent award marks a major achievement for the Company and follows another recent patent covering our core technology.
  • The Company’s technology uses a digital breakthrough in electrical waveforms to provide deep and painless brain neural stimulation.

EMS is Transforming Conventional Fitness Training at SmartFit and its Franchises

Retrieved on: 
Wednesday, March 27, 2024

With celebrities like Liz Hurley, Heidi Klum, and Madonna endorsing its effectiveness, EMS training has piqued the curiosity of fitness enthusiasts worldwide, sparking a surge in interest and inquiries.

Key Points: 
  • With celebrities like Liz Hurley, Heidi Klum, and Madonna endorsing its effectiveness, EMS training has piqued the curiosity of fitness enthusiasts worldwide, sparking a surge in interest and inquiries.
  • Those utilizing EMS suits exhibited significant improvements in body circumference and cardiovascular function, hinting at the potential of EMS training to yield notable fitness gains.
  • Lara Oliveira, wife and mother of three children, spearheads SmartFit , the first EMS training fitness studio in Georgia, with a passion for revolutionizing the fitness landscape.
  • Inspired by her own struggles to juggle motherhood and fitness, Lara stumbled upon EMS training during a visit to her native Brazil in 2018.

DEADLINE ALERT for RILY, EVVTY, ADM, and EAF: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, March 25, 2024

LOS ANGELES, March 25, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, March 25, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

EAF DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages GrafTech International Ltd. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action – EAF

Retrieved on: 
Sunday, March 24, 2024

WHAT TO DO NEXT: To join the GrafTech class action, go to https://rosenlegal.com/submit-form/?case_id=22210 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the GrafTech class action, go to https://rosenlegal.com/submit-form/?case_id=22210 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Precision Neuroscience Expands Clinical Research In Brain–Computer Interface

Retrieved on: 
Friday, March 22, 2024

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced the launch of two new clinical study sites, at Mount Sinai Health System and Perelman School of Medicine at the University of Pennsylvania (Penn Medicine).

Key Points: 
  • NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced the launch of two new clinical study sites, at Mount Sinai Health System and Perelman School of Medicine at the University of Pennsylvania (Penn Medicine).
  • Its design allows for safe implantation and removal by neurosurgeons without causing harm to delicate brain tissue.
  • Dr. Ben Rapoport, Chief Science Officer and co-founder of Precision Neuroscience, underscored the significance of these studies in advancing both medical science and patient care.
  • This partnership aims to explore the diverse applications of high-resolution cortical surface arrays in clinical settings, ranging from intraoperative monitoring to neurocritical care.

Levi & Korsinsky Reminds GrafTech International Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2024 – EAF

Retrieved on: 
Thursday, March 21, 2024

NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in GrafTech International Ltd. ("GrafTech" or the "Company") (NYSE: EAF) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in GrafTech International Ltd. ("GrafTech" or the "Company") (NYSE: EAF) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of GrafTech investors who were adversely affected by alleged securities fraud between February 8, 2019 and August 3, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    EAF investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GrafTech International Ltd. (EAF)

Retrieved on: 
Thursday, March 21, 2024

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • The Company’s International operating license in Mexico was also determined to be no longer in effect.
  • On this news, GrafTech’s stock fell $0.45, or 8.5%, to close at $4.85 on September 19, 2022, thereby injuring investors.
  • Glancy Prongay & Murray LLP, Los Angeles